| Item Type | Name |
|
Academic Article
|
New therapeutics for chronic heart failure.
|
|
Academic Article
|
Review: B-type natriuretic peptide consistently predicts death and cardiovascular events in heart failure.
|
|
Academic Article
|
Obesity as a prognostic factor in chronic symptomatic heart failure.
|
|
Academic Article
|
Racial variations in quality of care and outcomes in an ambulatory heart failure cohort.
|
|
Academic Article
|
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
|
|
Academic Article
|
Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure.
|
|
Academic Article
|
Advances in the treatment of heart failure with a preserved ejection fraction.
|
|
Academic Article
|
Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Decreasing body temperature predicts early rehospitalization in congestive heart failure.
|
|
Academic Article
|
Reduction in BNP levels with treatment of decompensated heart failure and future clinical events.
|
|
Academic Article
|
Recognition and treatment of depression and anxiety symptoms in heart failure.
|
|
Academic Article
|
Depression and anxiety in ambulatory patients with heart failure.
|
|
Academic Article
|
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.
|
|
Academic Article
|
Variation by race in factors contributing to heart failure hospitalizations.
|
|
Academic Article
|
Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.
|
|
Academic Article
|
Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology.
|
|
Academic Article
|
Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure.
|
|
Academic Article
|
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.
|
|
Academic Article
|
Worsening renal function is not associated with response to treatment in acute heart failure.
|
|
Academic Article
|
The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
|
|
Academic Article
|
Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy.
|
|
Academic Article
|
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
|
|
Academic Article
|
Anti-angiotensin therapy: new perspectives.
|
|
Academic Article
|
The metabolic syndrome and mortality in an ethnically diverse heart failure population.
|
|
Academic Article
|
Treatment of patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Biomarkers of inflammation in heart failure.
|
|
Academic Article
|
Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus.
|
|
Academic Article
|
Mortality after hospitalization for heart failure in blacks compared to whites.
|
|
Academic Article
|
Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety.
|
|
Academic Article
|
Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship.
|
|
Academic Article
|
New predictive models of heart failure mortality using time-series measurements and ensemble models.
|
|
Academic Article
|
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure.
|
|
Academic Article
|
Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF).
|
|
Academic Article
|
Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.
|
|
Academic Article
|
Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial.
|
|
Academic Article
|
ACP Journal Club. Review: in systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets.
|
|
Academic Article
|
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
|
|
Academic Article
|
Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure.
|
|
Academic Article
|
Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
|
|
Academic Article
|
Impact of race on health care utilization and outcomes in veterans with congestive heart failure.
|
|
Academic Article
|
Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients?
|
|
Academic Article
|
Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
|
|
Academic Article
|
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
|
|
Academic Article
|
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
|
|
Academic Article
|
The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study.
|
|
Academic Article
|
Metformin use and mortality in ambulatory patients with diabetes and heart failure.
|
|
Academic Article
|
Diuretic strategies in patients with acute decompensated heart failure.
|
|
Academic Article
|
Obesity, leptin, and incident heart failure.
|
|
Academic Article
|
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network.
|
|
Academic Article
|
New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility.
|
|
Academic Article
|
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.
|
|
Academic Article
|
Ultrafiltration in decompensated heart failure with cardiorenal syndrome.
|
|
Academic Article
|
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
|
|
Concept
|
Heart
|
|
Concept
|
Heart Failure, Diastolic
|
|
Concept
|
Heart Valve Prosthesis
|
|
Concept
|
Heart-Assist Devices
|
|
Concept
|
Heart Block
|
|
Concept
|
Heart Valve Prosthesis Implantation
|
|
Concept
|
Heart Valves
|
|
Concept
|
American Heart Association
|
|
Concept
|
Heart Transplantation
|
|
Concept
|
Heart Failure
|
|
Concept
|
Heart Valve Diseases
|
|
Concept
|
Heart Diseases
|
|
Concept
|
Heart Function Tests
|
|
Concept
|
Heart Rate
|
|
Academic Article
|
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery.
|
|
Academic Article
|
Incident cancer in patients with heart failure: causation or mere association?
|
|
Academic Article
|
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
|
|
Academic Article
|
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
|
|
Academic Article
|
Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.
|
|
Academic Article
|
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
|
|
Academic Article
|
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
|
|
Academic Article
|
Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction.
|
|
Academic Article
|
Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension.
|
|
Academic Article
|
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.
|
|
Academic Article
|
Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study.
|
|
Academic Article
|
Transitions of care in heart failure: a scientific statement from the American Heart Association.
|
|
Academic Article
|
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
|
|
Academic Article
|
Response to Letter Regarding Article, ?Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction?.
|
|
Academic Article
|
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
|
|
Academic Article
|
Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.
|
|
Academic Article
|
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
|
|
Academic Article
|
Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
|
|
Academic Article
|
Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
|
|
Academic Article
|
ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality.
|
|
Academic Article
|
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
|
|
Academic Article
|
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
|
|
Academic Article
|
Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
|
|
Academic Article
|
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
|
|
Academic Article
|
Aldosterone Receptor Blockers in the Treatment of Heart Failure.
|
|
Academic Article
|
Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine.
|
|
Academic Article
|
Observation Versus Inpatient Stay for Heart Failure: Is It Semantics?
|
|
Academic Article
|
Prevention of "Failure": Is It a Failure of Prevention?
|
|
Academic Article
|
De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes.
|
|
Academic Article
|
NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF.
|
|
Academic Article
|
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction.
|
|
Academic Article
|
Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD.
|
|
Academic Article
|
In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF.
|
|
Academic Article
|
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry.
|
|
Academic Article
|
Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease.
|
|
Grant
|
The Texas Medical Center Regional Coordinating Center for Heart Failure
|
|
Academic Article
|
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee.
|
|
Academic Article
|
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
|
Academic Article
|
Recent Innovations, Modifications,?and?Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our?Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical?Practice?Guidelines.
|
|
Academic Article
|
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
|
|
Academic Article
|
Understanding by General Providers of the Echocardiogram Report.
|
|
Academic Article
|
Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes.
|
|
Academic Article
|
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
|
|
Academic Article
|
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
|
|
Academic Article
|
Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619.
|
|
Academic Article
|
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.
|
|
Academic Article
|
Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization.
|
|
Academic Article
|
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study.
|
|
Academic Article
|
Heart?Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint.
|
|
Academic Article
|
Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Iron deficiency and iron therapy in heart failure and chronic kidney disease.
|
|
Academic Article
|
Home Health Care Use and Post-Discharge Outcomes After Heart?Failure Hospitalizations.
|
|
Academic Article
|
Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study.
|
|
Academic Article
|
Modern Radiotherapy and Risk of Cardiotoxicity.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization.
|
|
Academic Article
|
COVID-19 myocarditis and long-term heart failure sequelae.
|
|
Academic Article
|
Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry.
|
|
Academic Article
|
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Obesity and Heart Failure with Preserved Ejection Fraction.
|
|
Academic Article
|
In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
|
|
Academic Article
|
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
|
|
Academic Article
|
Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.
|
|
Academic Article
|
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment.
|
|
Academic Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer.
|
|
Academic Article
|
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary.
|
|
Academic Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.
|
|
Academic Article
|
Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?
|
|
Academic Article
|
Myocardial Dysfunction in Patients with Cancer.
|
|
Academic Article
|
Advances in Multimodality Imaging in?Cardio-Oncology: JACC State-of-the-Art Review.
|
|
Academic Article
|
Bioprosthetic valve monitoring in patients with carcinoid heart disease.
|
|
Academic Article
|
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.
|
|
Academic Article
|
Safety and efficacy of transcatheter edge-to-edge repair (TEER) in patients with history of cancer.
|
|
Academic Article
|
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.
|
|
Academic Article
|
Catheter Ablation of Atrial Fibrillation in?Persons With HFpEF: We Can All Breathe Easier Now!
|
|
Academic Article
|
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
As We Embark on a Second Year.
|
|
Academic Article
|
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
|
|
Academic Article
|
SGLT2 Inhibitor Use and Risk of Clinical?Events in Patients With Cancer Therapy-Related Cardiac Dysfunction.
|
|
Academic Article
|
Noncardiac Comorbidities in Chronic?Heart Failure: More Is Worse, What Else Do We Know?
|
|
Academic Article
|
Optimizing Background Therapy for?Heart?Failure in Clinical Trials: Towards a More Objective Approach.
|
|
Academic Article
|
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint?Committee?on?Clinical Practice Guidelines.
|
|
Academic Article
|
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
CorrigendumCorrigendum to 'The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support' [The Journal of Heart and Lung Transplantation, Volume 42, Issue 4, April 2023, Pages e1-e64.
|
|
Academic Article
|
Deep learning-based automatic segmentation of cardiac substructures for lung cancers.
|
|
Academic Article
|
Limitations of Apical Sparing Pattern in Cardiac Amyloidosis: A Multicenter Echocardiographic Study.
|
|
Academic Article
|
Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure.
|
|
Academic Article
|
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
Moving theory and reality closer together in cardio-oncology training.
|